Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 27, 2013
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle, Kim Plattner, Jonathan P Bestwick, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 31, 2018
Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease
Alastair J Noyce, John Dickson, Richard N Rees, et al.
NPJ Parkinson'S Disease
|
April 2, 2021
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm
Jonathan P Bestwick, Stephen D Auger, Cristina Simonet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 6, 2013
PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results
Alastair J Noyce, Jonathan P Bestwick, Laura Silveira-Moriyama, et al.
NPJ Parkinson'S Disease
|
July 3, 2026
Sternum-worn vibrotactile device in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot trial
Viktoria Azoidou, Essa Bhadra, Ellen Camboe, et al.
Plos One
|
September 28, 2013
Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
Johanna Gaiottino, Niklas Norgren, Ruth Dobson, et al.
The Lancet Regional Health. Europe
|
May 13, 2022
Dementia risk in a diverse population: A single-region nested case-control study in the East End of London
Phazha L K Bothongo, Mark Jitlal, Eve Parry, et al.
The Lancet. Diabetes & Endocrinology
|
February 29, 2020
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Ida Pernicova, Stephen Kelly, Sharon Ajodha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 17, 2017
PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease
Alastair J Noyce, Lea R'Bibo, Luisa Peress, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 30, 2010
Perchlorate and thiocyanate exposure and thyroid function in first-trimester pregnant women
Elizabeth N Pearce, John H Lazarus, Peter P A Smyth, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 27, 2013
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle, Kim Plattner, Jonathan P Bestwick, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 31, 2018
Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease
Alastair J Noyce, John Dickson, Richard N Rees, et al.
NPJ Parkinson'S Disease
|
April 2, 2021
Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm
Jonathan P Bestwick, Stephen D Auger, Cristina Simonet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 6, 2013
PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results
Alastair J Noyce, Jonathan P Bestwick, Laura Silveira-Moriyama, et al.
NPJ Parkinson'S Disease
|
July 3, 2026
Sternum-worn vibrotactile device in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot trial
Viktoria Azoidou, Essa Bhadra, Ellen Camboe, et al.
Plos One
|
September 28, 2013
Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
Johanna Gaiottino, Niklas Norgren, Ruth Dobson, et al.
The Lancet Regional Health. Europe
|
May 13, 2022
Dementia risk in a diverse population: A single-region nested case-control study in the East End of London
Phazha L K Bothongo, Mark Jitlal, Eve Parry, et al.
The Lancet. Diabetes & Endocrinology
|
February 29, 2020
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Ida Pernicova, Stephen Kelly, Sharon Ajodha, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 17, 2017
PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease
Alastair J Noyce, Lea R'Bibo, Luisa Peress, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 30, 2010
Perchlorate and thiocyanate exposure and thyroid function in first-trimester pregnant women
Elizabeth N Pearce, John H Lazarus, Peter P A Smyth, et al.
Page
of 11